SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Short Interest Update

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) saw a large growth in short interest in the month of February. As of February 13th, there was short interest totaling 781,872 shares, a growth of 21.1% from the January 29th total of 645,905 shares. Approximately 15.0% of the shares of the company are sold short. Based on an average daily volume of 119,993 shares, the short-interest ratio is presently 6.5 days. Based on an average daily volume of 119,993 shares, the short-interest ratio is presently 6.5 days. Approximately 15.0% of the shares of the company are sold short.

SPDR S&P Pharmaceuticals ETF Stock Performance

XPH opened at $56.61 on Thursday. The firm has a market cap of $294.37 million, a P/E ratio of 14.28 and a beta of 0.60. The firm has a 50-day moving average of $56.64 and a 200 day moving average of $52.30. SPDR S&P Pharmaceuticals ETF has a fifty-two week low of $35.22 and a fifty-two week high of $58.84.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of XPH. Envestnet Asset Management Inc. purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth about $10,732,000. Envestnet Portfolio Solutions Inc. grew its stake in SPDR S&P Pharmaceuticals ETF by 6.7% during the third quarter. Envestnet Portfolio Solutions Inc. now owns 171,930 shares of the company’s stock valued at $8,242,000 after acquiring an additional 10,842 shares in the last quarter. Park Avenue Securities LLC bought a new stake in SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth approximately $485,000. Orion Porfolio Solutions LLC bought a new stake in SPDR S&P Pharmaceuticals ETF during the 4th quarter worth approximately $244,000. Finally, Principal Securities Inc. lifted its stake in SPDR S&P Pharmaceuticals ETF by 18.1% in the 4th quarter. Principal Securities Inc. now owns 6,151 shares of the company’s stock worth $345,000 after purchasing an additional 941 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.